One of the best candidates is Anastrozole (Arimidex), an aromatase inhibitor that blocks estrogen production, approved by FDA and EMA (European Medicines Agency) to treat breast cancer in postmenopausal women (Table 1). The gene discussed is CYP19A1; the disease is breast carcinoma.